High-flow oxygen versus standard oxygen for altitude lung swelling
Part of Lungs & breathing clinical trials.
This trial tests whether high-flow oxygen (delivered through a special nasal tube) works better than standard oxygen therapy for a condition called high-altitude pulmonary edema (HAPE)—fluid buildup in the lungs caused by rapid ascent to high altitude. The study aims to see which approach helps patients breathe better and recover faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your symptoms (shortness of breath, cough, or trouble exercising) started within 7 days of traveling above 2,500 meters (8,200 feet) in altitude
- You have a confirmed diagnosis of HAPE with specific symptoms and clinical signs, plus imaging proof (chest X-ray or CT scan) showing fluid in your lungs
- You cannot or do not want to descend to lower altitude right now
- You are willing and able to give written informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a common heart feature, called a patent foramen ovale (a small flap between the upper chambers), affects the heart's response to low oxygen, such as at high altitudes. Participation may help researchers understand why some people develop fluid in the lungs at high altitude and could lead to better prevention or treatment.
This trial tests if inhaled nitric oxide helps people with high-altitude pulmonary edema (fluid in the lungs from high altitude). It may offer a new treatment option for those with mild to moderate symptoms.
This study tests new ways to diagnose and treat severe altitude sickness, a serious condition that can develop when people climb too quickly to high elevations. It may help doctors identify and treat the condition faster, potentially preventing complications.
This study looks at how the right side of the heart responds to low oxygen levels in people who have had high altitude pulmonary edema (HAPE) in the past. It will help researchers better understand right heart function.
This trial tests if Advair HFA affects how likely someone is to develop High Altitude Pulmonary Edema (HAPE), a serious lung condition at high altitudes. It compares people who are prone to HAPE, those who are resistant, and healthy controls.
This trial tests whether high-flow oxygen therapy (given through the nose) can help people in the emergency room whose oxygen levels are low due to a lung infection or other lung problem, without needing a breathing tube right away. It compares this to standard oxygen therapy through a mask.
Hear when a new High-altitude Pulmonary Edema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.